InnoONE™ is part of a fully integrated CDMO service from Servier, offering end-to-end support to bring your high potent product to market. Building on a foundation of more than 30 years of experience at our Arklow facility in Ireland, including over a decade in high containment activity, we have installed a new, state-of-the-art OEB5 suite at this location, enabling manufacturing to <1μg/m3.
The new suite was designed and engineered to maximize containment using a 3-tier approach – covering each piece of equipment, each room, and the self-contained suite itself. This optimizes process efficiency and risk mitigation, so your project moves faster with no compromises in exceptional quality and reliability.
At all times, quality is at the forefront of our InnoONE™ high potent service. A dedicated team operates the high containment suite, expertly guiding every project. Throughout the process, we are client focused and our single product philosophy means the entire suite is dedicated to one client and project at a time.
Servier is committed to oncology and high potent manufacturing through it’s own pipeline. Arklow is Servier’s second largest site and has a 30-year legacy, including 10 years in high containment. InnoONE™ integrates with other capabilities across 11 sites, including our InnoPrep™ technology for purification of HPAPIs down to OEB5.
Servier is committed to long-term partnerships and brings you know-how from commercialization of 50 molecules over 60 years. We are unrelenting in our pursuit of excellence. Let us bring that excellence to your high potent project.
New high containment suite mitigates risk and shortens your timelines for OEB5 products